BGLC — Bionexus Gene Lab Balance Sheet
0.000.00%
HealthcareHighly SpeculativeSmall CapSucker Stock
- $195.19m
- $194.62m
- $13.36m
- 41
- 10
- 14
- 10
Annual balance sheet for Bionexus Gene Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.839 | 0.659 | 0.366 | 0.7 | 0.579 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.128 | 0.023 | 0.016 | 4.02 | 3.44 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1 | 1.3 | 0.883 | 7.99 | 7.15 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.273 | 0.342 | 0.336 | 1.85 | 1.68 |
Long Term Investments | |||||
Total Assets | 1.27 | 1.65 | 1.23 | 10.1 | 9.57 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.17 | 0.063 | 0.052 | 3.37 | 2.33 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.18 | 0.13 | 0.109 | 3.45 | 2.39 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.095 | 1.52 | 1.12 | 6.66 | 7.18 |
Total Liabilities & Shareholders' Equity | 1.27 | 1.65 | 1.23 | 10.1 | 9.57 |
Total Common Shares Outstanding |